METFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE) — FDA Approval ANDA207427 (REGCON HOLDINGS)
METFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE) — FDA Approval ANDA207427 (REGCON HOLDINGS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: METFORMIN HYDROCHLORIDE; Active ingredients: METFORMIN HYDROCHLORIDE; Application number: ANDA207427.
| Brand name | METFORMIN HYDROCHLORIDE |
|---|---|
| Active ingredients | METFORMIN HYDROCHLORIDE |
| Application number | ANDA207427 |
| Sponsor | REGCON HOLDINGS |
| Dosage form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20161213 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →